Business
Pediatrix Medical Group Announces $250 Million Share Repurchase Program
FORT LAUDERDALE, Fla., August 18, 2025--Pediatrix Medical Group Announces $250 Million Share Repurchase Program
About this update from Pediatrix Medical Group, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":309,"url":"https://media.zenfs.com/en/business-wire.com/fae4ae3b640095147c76457114c72b66"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KNhLEEHiMgpo_AYiTq5XnA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTYxODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fae4ae3b640095147c76457114c72b66","width":480,"height":309}},"lazy":false},{"type":"text","content":"FORT LAUDERDALE, Fla., August 18, 2025--(BUSINESS WIRE)--Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced that its Board of Directors has authorized a share repurchase program of up to $250 million of the Company’s outstanding common stock.","length":291,"tagName":"p"},{"type":"text","content":""In view of our strong cash flow, current and forecasted cash balances and relatively low debt levels, our Board has authorized a $250 million share repurchase program, which we plan to use opportunistically," said Mark S. Ordan, Chair of the Board and Chief Executive Officer. "We will weigh the use of the repurchase program continually against other potential strategic uses of cash to provide the best long-term return to our shareholders and the strongest future for our business."","length":506,"tagName":"p"},{"type":"text","content":"The timing and actual number of shares repurchased will depend on a variety of factors, including market price of the shares, general business and market conditions, applicable legal requirements, and alternative investment opportunities. The Company intends to execute the repurchase program consistent with its capital allocation strategy of prioritizing investment to grow the business over the long term.","length":408,"tagName":"p"},{"type":"text","content":"Repurchases may be made through privately negotiated transactions or open market transactions, including pursuant to a trading plan in accordance with Rule 10b5-1 and/or Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The repurchase program has a three-year term and may be suspended for periods or discontinued at any time.","length":343,"tagName":"p"},{"type":"text","content":"ABOUT PEDIATRIX MEDICAL GROUP","length":29,"tagName":"p"},{"type":"text","content":"Pediatri...